Description: InMed Pharma (CSE: IN, OTCQB: IMLFF) is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.
March 12, 2018
InMed to Present at 30th Annual ROTH Capital Conference
Want to learn more about InMed Pharmaceuticals?
Note: page will reload once form is submitted.
#340-200 Granville Street
Canada V6C 1S4
Phone: (604) 669-7207
Email: [email protected]